Why I’m not a buyer of Lloyds Banking Group plc after recent declines

Check out why this Fool is not interested in Lloyds Banking Group plc (LON: LLOY) despite its low price.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Before the financial crisis, Lloyds (LSE: LLOY) was a cash cow. The bank’s simple business model helped it capitalise on the UK’s booming economy. Cash reserves swelled and the bank couldn’t return enough cash to shareholders. Unfortunately, Lloyds’ beneficial position drove the bank’s management to acquire HBOS during September 2008. Management was eager to grow the business and HBOS seemed to be, at the time, low-hanging fruit.

The problems HBOS and Lloyds had following the merger are well documented as Lloyds paid the price for reckless lending at HBOS over the years.

However, after several years of turmoil it’s nearly back to its former self. The bank’s capital position is robust, return on equity is in the mid-teens and the group has plans to pay out a substantial dividend to investors going forward. Specifically, at the end of the first half, the bank reported a common equity Tier 1 ratio of 13%, a tangible net asset value per share of 55p and a return on required equity of 14%. Total income was reported at £8.9bn. Alongside these results management declared an interim ordinary dividend of 0.85p per share, up 13% up year-on-year.

Not attractive

Despite these positive operating metrics, I’m not attracted to Lloyds. You see, it would appear that the bank is now suffering from the same problem that it did nearly 10 years ago. The group is generating plenty of cash, but growth is proving elusive. Competition in the UK’s banking sector is increasing and low interest rates are squeezing Lloyds’ net interest margin. That’s the difference between what the bank pays its depositors in interest and what it receives in interest on loans.

After several years of steady earnings growth and revenue recovery, City analysts are now cautious about the outlook for the bank’s earnings for the next few years. Indeed, analysts have pencilled-in an earnings decline of 14% for the year ending 31 December 2016 and a further decline of 13% for the year after. The current figures suggest the bank is set to report earnings per share of 6.4p for 2017, around one-third less than the figure of 8.5p reported for 2015. Hopefully, Lloyds has learnt its lesson and won’t go chasing growth at any price this time round as it did with HBOS in 2008.

But despite stagnating earnings, the City expects Lloyds’ dividend payout per share to grow during the next two years a dividend of 3.4p per share is predicted for 2017. At current prices this would equate to a yield of 5.7%.

The bottom line

So, while Lloyds has returned to its roots as a champion income investment, the bank is struggling to grow and for this reason, I’m not interested. Banking is an unpredictable industry and for dividends, I would rather look to the typical FTSE 100 dividend stalwarts such as GlaxoSmithKline and Royal Dutch Shell.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Rupert Hargreaves owns shares of GlaxoSmithKline and Royal Dutch Shell B. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Royal Dutch Shell B. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »